|
|
Post by sportsrancho on Feb 9, 2017 9:48:39 GMT -5
They can't come to soon! A friend of mine who had told a T2 about Afrezza told him she came back from asking for a script and said she couldn't get one. The Endo said no, they stopped making that. I hope she set the endo straight and demanded it. But I know what your saying.. If it's being advertised they will understand that it's going to still be available.. No she believed her doctor. Now she has to wait months for another appointment. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 9, 2017 10:02:50 GMT -5
I hope she set the endo straight and demanded it. But I know what your saying.. If it's being advertised they will understand that it's going to still be available.. No she believed her doctor. Now she has to wait months for another appointment. vdex? |
|
|
|
Post by sportsrancho on Feb 9, 2017 10:13:30 GMT -5
No she believed her doctor. Now she has to wait months for another appointment. vdex? Yes:-) I'm on it! |
|
|
|
Post by kball on Feb 9, 2017 10:40:19 GMT -5
They can't come to soon! A friend of mine who had told a T2 about Afrezza told him she came back from asking for a script and said she couldn't get one. The Endo said no, they stopped making that. Group cry anyone? Feel like Bill Murray in Caddyshack chasing that gopher |
|
|
|
Post by sweedee79 on Feb 9, 2017 10:54:45 GMT -5
I don't think any of the R/S stuff would even matter if we started seeing spikes in script numbers. It definitely looks like insurance coverage has improved but there is no exposure, whatsoever, other than from posts and efforts by user/advocates. SNY totally botched the launch with sample packs,lack of understanding with titration, sprirometry,etc... but at least they put out some print ads in major publications. Lets face it, word of mouth recommendations aren't going to get this company where it needs to be in the near-term. If script number stay stagnant after we have a reverse split, the shorts will walk it back down till they don't need to cover. Location, location, location, translates to exposure , exposure, exposure in the pharmacy space, and we have none. Gild isn't the best one to reference these days but early on they had very little insurance coverage but they advertised in every media outlet they could find. I would rather have mgmt. say wtf, like in risky business, and promote they hell out of Afrezza than continue with the slow painful death play. Just my two cents,thats all I have left. Roques, You are spot on! Bottom line is MNKD needs to advertise AFREZZA!We need the exposure! Everyone that I have ever talked to about AFREZZA and how it performs, is interested in it! MNKD needs to spark the interest in AFREZZA! ADVERTISE!!R/S could possibly be avoided if they move on this asap. If they don't, It just does not make sense! Two plus years after FDA Approval and no advertisement...No wonder we are facing delisting, r/s, after dilution, after dilution. It just does not make sense! GLTA TRUE LONGS! I agree... we now need to advertise... I believe they wanted to lay the ground work before they did ads... they have had enough time to do that ... we need to advertise... even PWD are asking why we aren't advertising... it would give Afrezza credibility and create demand..
My question is how much would it cost??? Do we have the money to do it?? Will dilution be enough?? We need a large scale DTC ... not a small one.. I would like to hear thoughts from the board about this issue... particularly the cost of advertising .. I believe that dilution wouldn't be so bad if the money were spent on something that substantially increased sales... we are at a point now where it is crucial that we not take baby steps anymore.. the company has to prove itself very soon...
|
|
|
|
Post by surplusvalue on Feb 9, 2017 11:46:44 GMT -5
Roques, You are spot on! Bottom line is MNKD needs to advertise AFREZZA!We need the exposure! Everyone that I have ever talked to about AFREZZA and how it performs, is interested in it! MNKD needs to spark the interest in AFREZZA! ADVERTISE!!R/S could possibly be avoided if they move on this asap. If they don't, It just does not make sense! Two plus years after FDA Approval and no advertisement...No wonder we are facing delisting, r/s, after dilution, after dilution. It just does not make sense! GLTA TRUE LONGS! With all do respect Carefull we really need to give MNKD some credit. The first year sanofi owned the marketing aspect of Afrezza and MNKDs hands were tied. Its been a little more then a year Since Sanofi termination notice and Sanofi still had its grip and the official termination wasn't until July maybe 7 months. So since then MNKD was strapped for cash. Im sure MNKD wants advertisement and commercials also and they have been working on them for as far as we know at least 3 months now and are in the process of FDA approval. They are coming.. Credit? Dont make me puke. MNKD particpated in the agreement with Sanofi and tied their own hands. It's managements own ineptitude that was equally responsible in producing this outcome. Regardless of the change in leadership at Sanofi MNKD handed over almost complete control to Sanofi for what even then many expressed as a bad deal for MNKD. Where is the filing for Europe that Al promised? Where is the pediatric trial completion so necessary a component for sales and where is the advertising besides a few programs at a ball game? Please. |
|
|
|
Post by dh4mizzou on Feb 9, 2017 11:55:30 GMT -5
"The Endo said no, they stopped making that."
Not to be too big of a conspiracy theorist but where does this garbage come from? Would it be too far fetched to think that the other sales reps are spreading this tripe to keep their own territory clear of the drug?
|
|
|
|
Post by surplusvalue on Feb 9, 2017 12:00:57 GMT -5
Roques, You are spot on! Bottom line is MNKD needs to advertise AFREZZA!We need the exposure! Everyone that I have ever talked to about AFREZZA and how it performs, is interested in it! MNKD needs to spark the interest in AFREZZA! ADVERTISE!!R/S could possibly be avoided if they move on this asap. If they don't, It just does not make sense! Two plus years after FDA Approval and no advertisement...No wonder we are facing delisting, r/s, after dilution, after dilution. It just does not make sense! GLTA TRUE LONGS! I agree... we now need to advertise... I believe they wanted to lay the ground work before they did ads... they have had enough time to do that ... we need to advertise... even PWD are asking why we aren't advertising... it would give Afrezza credibility and create demand..
My question is how much would it cost??? Do we have the money to do it?? Will dilution be enough?? We need a large scale DTC ... not a small one.. I would like to hear thoughts from the board about this issue... particularly the cost of advertising .. I believe that dilution wouldn't be so bad if the money were spent on something that substantially increased sales... we are at a point now where it is crucial that we not take baby steps anymore.. the company has to prove itself very soon...
Problem is that first Sanofi didnt lay much groundwork but then MNKD, once it gained back control, did not make significant groundwork first either. We were told by MNKD that they would first fully engage education and then DTC. Problem is we now know they didnt fully engage education since the sales force turned out to be almost half what we were led to believe. There is almost no awareness of Afrezza and MNKD at the last CC even admitted this. Yet they knew for almost a full year that Sanofi poisoned the well and were telling people it was not going to be available. They have done almost nothing to counter this lack of awareness. Even shareholders can readily see this problem. They now need full scale DTC and dont have the funding for this. They may not have needed this full scale if they had engaged the awareness problem throughout last year.Very sad situation. Not everything can be faulted by reference to Sanofi, the responsibility for this mess is MNKD's as well despite their hard work and commitment. |
|
|
|
Post by surplusvalue on Feb 9, 2017 12:14:10 GMT -5
"The Endo said no, they stopped making that."
Not to be too big of a conspiracy theorist but where does this garbage come from? Would it be too far fetched to think that the other sales reps are spreading this tripe to keep their own territory clear of the drug?
No conspiracy. It was communicated by Sanofi and their reps. MNKD knew this was happening when they went to the ADA conference soon after the breakup with Sanofi and found that people there thought MNKD was done and that Afrezza was not available. Mnkd knew about this a long time ago and has done little to counter it (obviously from this example) When MNKD went to the ADA they could hear Sanofi singing this in the background. www.youtube.com/watch?v=PwXai-sgM-s |
|
|
|
Post by agedhippie on Feb 9, 2017 12:55:27 GMT -5
"The Endo said no, they stopped making that."
Not to be too big of a conspiracy theorist but where does this garbage come from? Would it be too far fetched to think that the other sales reps are spreading this tripe to keep their own territory clear of the drug?
Yes it would be too far fetched. The doctor hears some mumbling about Sanofi dropping the product, Sanofi reps stop talking about it since they no longer get a commission on sales, nobody turns up to sell it to him - it's not exactly a stretch to think it's no longer available. |
|
|
|
Post by surplusvalue on Feb 9, 2017 15:31:20 GMT -5
The more I examine the situation and the CEO's inane remarks the more I am struck by the fact that even a 1 for 10 may not provide a feasible basis for financing if the stock continues to fall prior to the vote and if it subsequently it gets pounded down before an actual RS and additionally so after a RS takes place. I keep reminding everyone that this is a targeted stock, and those who would like to see MNKD fail may be waiting just for this opportunity to do some more serious damage to the stock. Unless they have something to back up and support the RS then MNKD may be setting itself up for a situation that brings them back to a delisting situation sooner than expected especially if sales only percolate slowly as has been the case. What's your issue with the particular ratio... that it would be harder to do equity offering if share price is below $5 (limit for some funds to invest)? I'm just following the logic of your own post. If the share price keeps falling before the vote, after the vote and also after an RS and shorts etc pile on to this after the RS then the share price could be driven so low that a equity raise (even after a 1 for 10) might put MNKD in a precarious position again with respect to its listing sooner than expected. And the $5 minimum to allow for any further institutional buy in will be far removed. They will have executed (thats the right word here) all of this for little real long term gain. I am especially concerned since we have CEO who is saying that this is being done from "a position of strength" and also saying he doesnt see what the concern is about a RS. What?  ?? A good CEO always considers the possibility of failure to then examine what he'she could do to counteract the possible negative of what they are planning. Someone who doesnt even see the negative possibilities is ill prepared and shouldnt be running any company. If they dont have anything to support the RS and or dilution I think we are going to be in real serious trouble. They will have sacrificed existing shareholders (especially underwater ones) for very little good reason. |
|
|
|
Post by cedafuntennis on Feb 9, 2017 17:01:23 GMT -5
We have the money to hire tens of directors and VPs yet we don't have the money to advertise when Matt promised to do just that in his last qtr call??? Makes one wonder...
|
|
|
|
Post by uvula on Feb 9, 2017 17:26:01 GMT -5
People are willing to accept stock options in lieu of money. Advertisers are not. (While these statements are true I do not know if they have any relevance to our situation.)
|
|
|
|
Post by roguesuerte on Feb 9, 2017 23:56:23 GMT -5
One thing that bothers me is that mnkd is not a BP organization, and we are no longer tethered to one. all this stuff about advertising and exposure is a no brainer to anyone, at this juncture. I think part of the problem we have here is a mgmt. team that do not know how to use stealth to their advantage, and have never been encouraged to do so.Hakan resignsout of the blue but he gets compensation for two years salary. This type of treatment sends a message to inept mgmt. that we 'take care of our own' even when you suck because its for the patients. I saw a post on Diabetes mine that they are working on a commercial, and are down to a few options but IMHO this should have happened as soon as SNY backed out. How many failed launches do you get before complete failure? In my appriximation this is their last opportunity, save an outright sale.
|
|
|
|
Post by BlueCat on Feb 10, 2017 14:38:03 GMT -5
Justa thought (since others on the board have suggested some nice foil hat) -
Imagine there are short interests out there that know Mann's estate interest has these shares. If after R/S, they dilute and shorts push it all the way down again - maybe requiring yet another R/S - they know they are killing Mann's legacy - not just MNKD/Afrezza, but potentially have $Bs impact on what's left of the estate .... Possible there is some personal ill-will out there? (Beyond Shrek?)
|
|
